Arcutis Biotherapeutics Inc

Stock Chart, Company Information, and Scan Results

$14.77(as of Aug 8, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Arcutis Biotherapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$14.77
Ticker SymbolARQT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees342
CountyUSA
Market Cap$1,771.0M
EBIDTA-80.1M
10-Day Moving Average14.75
P/E Ratio-20.11
20-Day Moving Average14.90
Forward P/E Ratio0.00
50-Day Moving Average14.28
Earnings per Share-0.76
200-Day Moving Average13.45
Profit Margin-19.49%
RSI51.21
Shares Outstanding119.9M
ATR0.86
52-Week High17.75
Volume2,613,468
52-Week Low8.03
Most Recent Support Level13.97
Book Value139.0M
Most Recent Resistance Level16.39
P/B Ratio13.50
Upper Keltner16.84
P/S Ratio7.12
Lower Keltner12.96
Debt-to-Equity Ratio16.84
Next Earnings Date11/05/2025
Cash Surplus-30.9M
Next Ex-Dividend DateUnknown

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE foam for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-255, a selective small molecule inhibitor of JAK1 for the treatment of alopecia areata; ARQ-252, a JAK1-selective topical cream in development for hand eczema and vitiligo; and ARQ-234, a CD200R fusion protein for the treatment of atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Arcutis Biotherapeutics Inc In Our Stock Scanner

As of Aug 08, 2025
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.